default author photo

Shannon Gibson

University of Toronto Faculty of Law

Research Associate

105 St George Street

Toronto, Ontario M5S 3G8

Canada

http://www.linkedin.com/in/shannongibson

SCHOLARLY PAPERS

9

DOWNLOADS

1,594

TOTAL CITATIONS

3

Scholarly Papers (9)

1.

The Case for Improved Post-Market Surveillance of Pharmaceuticals

Number of pages: 8 Posted: 20 Oct 2013 Last Revised: 14 Apr 2014
Trudo Lemmens and Shannon Gibson
University of Toronto - Faculty of Law and University of Toronto Faculty of Law
Downloads 428 (170,272)

Abstract:

Loading...

pharmaceutical policy, drug regulation, post-market surveillance, adverse drug reactions, off-label prescribing

2.

Decreasing the Data Deficit: Improving Post-Market Surveillance in Pharmaceutical Regulation

McGill Law Journal 2014; 59(4) 943-988.
Number of pages: 46 Posted: 10 Dec 2014
Trudo Lemmens and Shannon Gibson
University of Toronto - Faculty of Law and University of Toronto Faculty of Law
Downloads 281 (272,209)

Abstract:

Loading...

Pharmaceutical Regulation; post-marketing surveillance; adverse drug reactions; transparency; clinical trials

3.

Why the Shift? Taking a Closer Look at the Growing Interest in Niche Markets and Personalized Medicine

Gibson, S., Raziee, H. R. and Lemmens, T. (2015), Why the Shift? Taking a Closer Look at the Growing Interest in Niche Markets and Personalized Medicine. World Medical & Health Policy, 7: 3–27. doi: 10.1002/wmh3.131
Number of pages: 25 Posted: 14 Apr 2015 Last Revised: 22 Apr 2015
Shannon Gibson, Hamid Raziee and Trudo Lemmens
University of Toronto Faculty of Law, University of Toronto and University of Toronto - Faculty of Law
Downloads 210 (364,680)

Abstract:

Loading...

pharmacogenomics, personalized medicine, pharmaceuticals, niche markets

4.

The Promise and Peril of Adapting the Regulatory System to the Pharmacogenomic Context

McGill Journal of Law and Health (2015) 8(2): S145-S230
Number of pages: 86 Posted: 26 Nov 2014 Last Revised: 13 Jun 2015
Shannon Gibson and Trudo Lemmens
University of Toronto Faculty of Law and University of Toronto - Faculty of Law
Downloads 179 (424,491)
Citation 2

Abstract:

Loading...

pharmacogenomics, pharmaceutical regulation, drug reform, drug policy

5.

Niche Markets and Evidence Assessment in Transition: A Critical Review of Proposed Drug Reforms

Medical Law Review, 2014, Forthcoming
Number of pages: 22 Posted: 12 Apr 2014
Shannon Gibson and Trudo Lemmens
University of Toronto Faculty of Law and University of Toronto - Faculty of Law
Downloads 165 (456,852)

Abstract:

Loading...

adaptive licensing, healthcare reform, pharmacogenetics, pharmaceutical regulation, drug reimbursement, risk-sharing agreements, data integrity, transparency, clinical trials

6.

Regulating Off-Label Prescribing: The Good, the Bad and the Uncertain

Number of pages: 10 Posted: 20 Oct 2013 Last Revised: 24 Nov 2014
Shannon Gibson and Trudo Lemmens
University of Toronto Faculty of Law and University of Toronto - Faculty of Law
Downloads 109 (649,907)

Abstract:

Loading...

off-label prescribing, pharmaceutical regulation

7.

Orphan Drug Incentives in the Pharmacogenomic Context: Policy Responses in the US and Canada

Shannon Gibson & Barbara von Tigerstrom, “Orphan drug incentives in the pharmacogenomic context: policy responses in the US and Canada” (2015) Journal of Law and the Biosciences, 1-29 doi:10.1093/jlb/lsv013
Number of pages: 29 Posted: 23 Apr 2015
Shannon Gibson and Barbara von Tigerstrom
University of Toronto Faculty of Law and University of Saskatchewan - College of Law
Downloads 88 (759,537)

Abstract:

Loading...

pharmaceutical policy, pharmacogenomics, orphan drug policy, rare diseases, Food and Drug Administration

8.

The Role of the Internet in Expanding Consumer-Driven Adverse Drug Reaction Reporting

Number of pages: 5 Posted: 19 Oct 2013 Last Revised: 25 Oct 2013
Shannon Gibson
University of Toronto Faculty of Law
Downloads 68 (907,769)

Abstract:

Loading...

adverse drug reactions, consumer reporting

9.

Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research

Journal of Empirical Research on Human Research Ethics, Forthcoming
Number of pages: 28 Posted: 27 Jul 2017
Shannon Gibson, Renata Axler and Trudo Lemmens
University of Toronto Faculty of Law, Odette School of Business and University of Toronto - Faculty of Law
Downloads 66 (916,100)
Citation 1

Abstract:

Loading...

Biobanks, Data access, transparency, accountability, commercialization, public trust